Crescent Sterling’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$818K Sell
9,010
-1,467
-14% -$134K 0.73% 38
2026
Q1
$1.08M Buy
10,477
+150
+1% +$16.9K 1.04% 29
2025
Q4
$1.29M Sell
10,327
-25
-0.2% -$3.19K 1.33% 23
2025
Q3
$1.39M Buy
10,352
+262
+3% +$34.4K 1.46% 24
2025
Q2
$1.37M Buy
10,090
+280
+3% +$36.9K 1.54% 21
2025
Q1
$1.3M Sell
9,810
-527
-5% -$67.1K 1.33% 24
2024
Q4
$1.17M Sell
10,337
-320
-3% -$37K 1.2% 24
2024
Q3
$1.22M Sell
10,657
-73
-0.7% -$8.01K 1.16% 25
2024
Q2
$1.11M Sell
10,730
-61
-0.6% -$6.47K 1.07% 31
2024
Q1
$1.23M Sell
10,791
-27
-0.2% -$3.1K 1.12% 30
2023
Q4
$1.19M Sell
10,818
-251
-2% -$25.1K 1.19% 28
2023
Q3
$1.07M Sell
11,069
-1,813
-14% -$190K 1.13% 30
2023
Q2
$1.4M Sell
12,882
-68
-0.5% -$7.25K 1.33% 25
2023
Q1
$1.31M Buy
12,950
+1,715
+15% +$181K 1.27% 25
2022
Q4
$1.23M Buy
+11,235
New +$1.16M 1.32% 25

Other funds holding ABT

Crescent Sterling's ABT Position: Q2 2026 in Review

Crescent Sterling reduced its Abbott (ABT) stake by 14% in Q2 2026, selling an estimated $134K and leaving 9,010 shares worth $818K. The position accounts for 0.73% of the portfolio, ranked #38.

Crescent Sterling first reported a position in ABT in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.4M in Q2 2023. 842 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Crescent Sterling held 9,010 shares of Abbott worth $818K as of Q2 2026.
  • Crescent Sterling sold 1,467 Abbott shares in Q2 2026, an estimated $134K.
  • Abbott made up 0.73% of Crescent Sterling's portfolio in Q2 2026, its #38 holding.
  • Crescent Sterling first reported a position in Abbott in Q4 2022 and has held it in 15 quarters since.
  • Crescent Sterling's Abbott position peaked at $1.4M in Q2 2023.
  • 842 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Crescent Sterling's 13F filing for Q2 2026, filed 7 Jul 2026.